8 results
P170: Safety and Tolerability of Brexpiprazole for the Treatment of Agitation in Alzheimer’s Dementia: Pooled Results From Three Phase III Trials
-
- Journal:
- International Psychogeriatrics / Volume 35 / Issue S1 / December 2023
- Published online by Cambridge University Press:
- 02 February 2024, pp. 259-260
-
- Article
-
- You have access
- Export citation
P96: Efficacy of Brexpiprazole for the Treatment of Agitation in Alzheimer’s Dementia: Post Hoc Line Item Analysis of the Cohen-Mansfield Agitation Inventory
-
- Journal:
- International Psychogeriatrics / Volume 35 / Issue S1 / December 2023
- Published online by Cambridge University Press:
- 02 February 2024, pp. 209-210
-
- Article
-
- You have access
- Export citation
Post hoc analysis of a randomised, placebo-controlled, active-reference 6-week study of brexpiprazole in acute schizophrenia
-
- Journal:
- Acta Neuropsychiatrica / Volume 32 / Issue 3 / June 2020
- Published online by Cambridge University Press:
- 14 February 2020, pp. 153-158
-
- Article
- Export citation
14 Long-term Efficacy of Brexpiprazole in Patients with Schizophrenia with Clinically Relevant Levels of Negative Symptoms
-
- Journal:
- CNS Spectrums / Volume 24 / Issue 1 / February 2019
- Published online by Cambridge University Press:
- 12 March 2019, p. 180
-
- Article
-
- You have access
- Export citation
Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians’ choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study
-
- Journal:
- CNS Spectrums / Volume 24 / Issue 5 / October 2019
- Published online by Cambridge University Press:
- 11 October 2018, pp. 507-517
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder
-
- Journal:
- Acta Neuropsychiatrica / Volume 31 / Issue 1 / February 2019
- Published online by Cambridge University Press:
- 18 September 2018, pp. 27-35
-
- Article
- Export citation
123 Adjunctive Brexpiprazole in Patients With MDD and Symptoms of Anxiety: Results From Post-Hoc Analyses of Three Placebo-Controlled Studies
-
- Journal:
- CNS Spectrums / Volume 23 / Issue 1 / February 2018
- Published online by Cambridge University Press:
- 15 June 2018, pp. 77-78
-
- Article
-
- You have access
- Export citation
Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies
-
- Journal:
- Acta Neuropsychiatrica / Volume 29 / Issue 5 / October 2017
- Published online by Cambridge University Press:
- 16 November 2016, pp. 278-290
-
- Article
- Export citation